Abstracts
Please see a list of successful abstracts below:
Oral Presentations
- OR01: Universal screening of colorectal cancers for Lynch syndrome by reflex immunohistochemistry – a single centre 9 year experience
- OR02: The LynCE study (The pilot): An assesment of endometrial cancer progression markers in Lynch syndrome
- OR03: Functional assays and bioinformatics predictions reveal a high contribution of splicing mutations in the most frequent forms of hereditary cancer
- OR04: Molecular diagnosis of inherited colorectal cancer using NGS panel
- OR05: Non-polypous colorectal cancer – a distinct tumour type in Lynch syndrome?
- OR06: DiagMMR: Functional Lynch syndrome carrier testing from skin
- OR07: Age stratified surveillance strategies Lynch syndrome-associated cancer according to mismatch repair mutation
- OR08: Young adult colorectal cancer incidence trends in Europe: an important clinical and research opportunity for the European Hereditary Tumour Group
- OR09: Frameshift mutations in microsatellite unstable colorectal cancers: from immune signature to personalized immunotherapy
- OR10: Technological innovation in hereditary cancer risk assessment
- OR11: Risk factors for the presence of pathogenic APC and biallelic MUTYH mutations in patients with multiple adenomas
- OR12: Chromocolonoscopy with indigo carmine facilitates high adenoma detection in Lynch syndrome patients
- OR13: Surveillance of Duodenal Polyposis in Familial Adenomatous Polyposis: Should the Spigelman score be modified?
- OR14: The Colon Cancer Family Registry Cohort and genetic factors for colorectal cancer
- OR15: Worldwide study of cancer risks for Lynch syndrome: International mismatch repair consortium (IMRC)
Short Oral Presentations
- SO01: Germline mutations in MMR genes among Russian patients with Lynch syndrome
- SO02: DNA mismatch repair genes deficiency is a frequent phenomenon in small intestine adenocarcinoma
- SO03: Evaluation of a 25-gene panel in patients with suspected Lynch syndrome: preliminary results from the FAMOSA study
- SO04: Targeted NGS of 22 mismatch repair genes identifies LS families
- SO05: Selective and universal screening strategies for Lynch syndrome: a perspective from the Royal Marsden Hospital
- SO06: Impact of an optimized colonoscopic screening program for patient with Lynch syndrome. Four years results of a specialized French network
- SO08: Identification of novel causal genes of hereditary colorectal cancer
- SO09: Elucidating the molecular basis of MSH2-deficient tumours in Lynch syndrome suspected patients
- SO10: Identification of genetic biomarkers for clinical management of familial colorectal cancer
- SO11: Endoscopic surveillance of the upper gastrointestinal tract in Lynch syndrome patients
- SO22: Colon polyps prevention and associated gut microbiota changes in a colorectal cancer animal model fed with functional meat foods containing prebiotics
- SO23: Renal cell carcinoma in Lynch Syndrome: a preliminary report from a Mallorca group collaborative study
- SO29: Screening of 274 familial colorectal cancer patients using a multi-gene panel
- SO30: Compliance and impact of colonoscopy in familial adenomatous polyposis and MYH-associated polyposis
- SO31: Do we still need surgery for treating small bowel polyps in Peutz-Jeghers Syndrome? A 13-years follow-up cohort
- SO33: Assessment of MUTYH Associated Polyposis (MAP) phenotype in order to refine testing guidelines
- SO34: A reassessment colonoscopy increases the diagnostic yield for serrated polyposis syndrome in a faecal immunochemical test (FIT)-based colorectal cancer screening population
- SO35: DNA-diagnostics of Familial Adenomatous Polyposis and Peutz-Jeghers syndrome among Russian patients
- SO36: Incidence of colonic neoplasia in patients with Serrated Polyposis Syndrome who undergo endoscopic surveillance: a multicenter study
Poster Presentations
- P7: Capsule endoscopy and magnetic resonance enterography for small bowel neoplasia screening in Lynch Syndrome
- P13: Data from 1100 families used to model investigation strategies in familial bowel cancer
- P14: Compliance and impact of screening of individuals at high risk of hereditary colorectal cancer
- P15: Diagnosis of Constitutional Mismatch Repair-Deficiency
- P16: Constitutive mismatch repair deficiency syndrome: clinical description in a French cohort
- P17: Can microsatellite instability be a useful parameter for tailoring adjuvant chemotherapy? A case report
- P18: Molecular analysis of unclassified variants in MLH1 and MSH2 genes
- P19: Identification of germline FAN1 variants in MSH2-deficient Lynch-like syndrome patients
- P20: Characterization of the clinical phenotype associated with the POLD1-Leu474Pro mutation
- P24: Improving colonoscopy quality through effective training
- P25: Preliminary Epidemiological results from the first four months of a pilot interpisciplinary model in identification of GI syndromic neoplasia
- P26: Practical therapeutic applications of ferromagnetic carbon nanotubes in colon cancer treatment
- P27: Chromoendoscopy in combination with random biopsies does not improve detection of gastric cancer foci in CDH1 mutation positive patients
- P32: Serrated Polyposis Syndrome: A multicentre cohort study
- P37: POLE mutations – The growing cancer specter and need for surveillance protocols
- P38: High prevalence of benign and malignant thyroid disease in patients with familial adenomatous polyposis (FAP)
- P39: Somatic mutations in MUTYH-associated Polyposis (MAP)
- P40: Deep intronic mutations may explain unbalanced expression of APC alleles in familial adenomatous polyposis
Poster Boards
Board size: 118.5 x 146 cm. Pins can be used to attach posters to the boards.
